Annunziata, C. M., Hernandez, L., Davis, R. E., Zingone, A., Lamy, L., Lam, L. T., . . . Staudt, L. M. (2011). A mechanistic rationale for MEK inhibitor therapy in myeloma based on blockade of MAF oncogene expression. American Society of Hematology.
Citação norma ChicagoAnnunziata, Christina M., et al. A Mechanistic Rationale for MEK Inhibitor Therapy in Myeloma Based On Blockade of MAF Oncogene Expression. American Society of Hematology, 2011.
Citação norma MLAAnnunziata, Christina M., et al. A Mechanistic Rationale for MEK Inhibitor Therapy in Myeloma Based On Blockade of MAF Oncogene Expression. American Society of Hematology, 2011.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.